PCM Acquires Stratiform, a Technology Leader in Microsoft Cloud-Based Solutions
Jan 03, 2017 14:01 pm UTC| Business
EL SEGUNDO, Calif., Jan. 03, 2017 -- PCM, Inc. (NASDAQ:PCMI) a leading North American technology solutions provider, today announced a strategic acquisition of Stratiform, Inc. (Stratiform), an industry-leading provider...
Jan 03, 2017 14:00 pm UTC| Business
HENDERSON, NV, Jan. 03, 2017 -- Double Crown Resources, Inc. (DDCC) is ready to enter 2017 with a commitment to bringing the advanced interlocking, intermodal transport system called Translock² (Translock Squared) into...
MannKind Receives $1 Million Milestone From RLS
Jan 03, 2017 14:00 pm UTC| Business
VALENCIA, Calif., Jan. 03, 2017 -- MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD)today confirmed that following the completion of initial formulation studies itreceiveda $1 million milestone payment from Receptor Life...
2017 Satellite Healthcare Norman S. Coplon Extramural Grant Program Now Accepting Applications
Jan 03, 2017 14:00 pm UTC| Business
SAN JOSE, Calif., Jan. 03, 2017 -- Satellite Healthcare, a leading not-for-profit dialysis care provider, is pleased to announce that the Norman S. Coplon Extramural Grant Program is now accepting applications for...
Poseida Therapeutics Appoints Debra Gessner as Vice President, Regulatory Affairs
Jan 03, 2017 14:00 pm UTC| Business
SAN DIEGO, Jan. 03, 2017 -- Poseida Therapeutics Inc., a San Diego-based company translating best-in-class gene editing technologies into lifesaving therapeutics, today announced that Debra Gessner has joined the...
JENSEN Tools + Supply Partners with DESCO to Offer Free ESD Control Survey to Its Customers
Jan 03, 2017 14:00 pm UTC| Business
NORTH ANDOVER, Mass., Jan. 03, 2017 -- JENSEN Tools + Supply recently celebrated 38 years of partnership with DESCO, a multinational firm that specializes in the manufacturing of products for ESD control in electronics...
Rexahn Pharmaceuticals to Present at Biotech Showcase™ 2017
Jan 03, 2017 14:00 pm UTC| Business
ROCKVILLE, Md., Jan. 03, 2017 -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing next generation therapeutics for the treatment of cancer, announced today that Peter D....